DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Rozerem (Ramelteon) - Adverse Event Reports - Hospitalization - Insomnia

 



Index of reports > Cases resulting in hospitalization (20) > Cases with Insomnia (4)

Below is the selection of adverse event reports related to Rozerem (Ramelteon) that includes cases resulting in hospitalization where reactions include insomnia.

Adverse event in 54 year old female receiving Rozerem (Ramelteon)

Reported by a consumer/non-health professional from United States on 2007-10-16

Patient: 54 year old female, weighing 68.0 kg (149.7 pounds)

Adverse reactions / side effects: Drug Ineffective, Drug Hypersensitivity, Headache, Swollen Tongue, Ill-Defined Disorder, Pharyngeal Oedema, Hallucinations, Mixed, Insomnia, Thyroid Disorder

Adverse event resulted in: hospitalization

Suspect drug(s):
Rozerem
    Dosage: 8 mg, qhs, per oral; 8 mg, qhs, per oral; 8 mg, qhs, per oral
    Administration route: Oral
    Indication: Insomnia
    Start date: 2007-09-01
    End date: 2007-09-01

Rozerem
    Dosage: 8 mg, qhs, per oral; 8 mg, qhs, per oral; 8 mg, qhs, per oral
    Administration route: Oral
    Indication: Insomnia
    Start date: 2007-08-01

Rozerem
    Dosage: 8 mg, qhs, per oral; 8 mg, qhs, per oral; 8 mg, qhs, per oral
    Administration route: Oral
    Indication: Insomnia
    Start date: 2007-09-01

Ambien CR
    Dosage: qhs, per oral
    Administration route: Oral
    Indication: Insomnia
    Start date: 2006-01-01
    End date: 2007-09-01

Imitrex
    Dosage: 50 mg, as required, per oral; 50 mg, as required, per oral
    Administration route: Oral
    Indication: Headache
    Start date: 2003-01-01
    End date: 2007-09-01

Imitrex
    Dosage: 50 mg, as required, per oral; 50 mg, as required, per oral
    Administration route: Oral
    Indication: Headache
    Start date: 2007-09-01

Unknown Sleep Medication (All Other Therapeutic Products)
    Indication: Sleep Disorder Therapy
    Start date: 2007-08-01
    End date: 2007-08-01

Other drugs received by patient: Vicodin; Flexeril; Unknown Anti-Inflammatory (All Other Therapeutic Products); Unknown Anti-Depressant (Antidepressants)



Adverse event in 57 year old male receiving Rozerem (Ramelteon)

Reported by a pharmacist from United States on 2007-10-12

Patient: 57 year old male, weighing 92.5 kg (203.6 pounds)

Adverse reactions / side effects: Blood Pressure Increased, Pneumonia, Incorrect Dose Administered, Benign Prostatic Hyperplasia, Disorientation, Abnormal Dreams, Dysarthria, Lung Disorder, Fatigue, Insomnia, Vision Blurred, Arthritis, Feeling Abnormal, Scar

Adverse event resulted in: hospitalization

Suspect drug(s):
Rozerem
    Dosage: 8 mg, qhs, per oral; 2 tablets, qhs, per oral; 8 mg, 1 tablet, qhs, per oral
    Administration route: Oral
    Indication: Insomnia
    Start date: 2006-01-01
    End date: 2007-09-06

Rozerem
    Dosage: 8 mg, qhs, per oral; 2 tablets, qhs, per oral; 8 mg, 1 tablet, qhs, per oral
    Administration route: Oral
    Indication: Insomnia
    End date: 2007-10-01

Rozerem
    Dosage: 8 mg, qhs, per oral; 2 tablets, qhs, per oral; 8 mg, 1 tablet, qhs, per oral
    Administration route: Oral
    Indication: Insomnia
    Start date: 2007-09-07

Other drugs received by patient: Citracal D (Ergocalciferol, Calcium Citrate); Atarax; Flomax; Zyrtec-D 12 Hour; Omega 6 (Omega-6 Fatty Acids); Benazepril HCL



Adverse event in 54 year old female receiving Rozerem (Ramelteon)

Reported by a consumer/non-health professional from United States on 2007-10-09

Patient: 54 year old female, weighing 68.0 kg (149.7 pounds)

Adverse reactions / side effects: Drug Ineffective, Drug Hypersensitivity, Headache, Swollen Tongue, Ill-Defined Disorder, Pharyngeal Oedema, Hallucinations, Mixed, Insomnia, Thyroid Disorder

Adverse event resulted in: hospitalization

Suspect drug(s):
Rozerem
    Dosage: 8 mg, qhs, per oral; 8 mg, qhs, per oral; 8 mg, qhs, per oral
    Administration route: Oral
    Indication: Insomnia
    Start date: 2007-09-01
    End date: 2007-09-01

Rozerem
    Dosage: 8 mg, qhs, per oral; 8 mg, qhs, per oral; 8 mg, qhs, per oral
    Administration route: Oral
    Indication: Insomnia
    Start date: 2007-08-01

Rozerem
    Dosage: 8 mg, qhs, per oral; 8 mg, qhs, per oral; 8 mg, qhs, per oral
    Administration route: Oral
    Indication: Insomnia
    Start date: 2007-09-01

Ambien CR
    Dosage: qhs, per oral
    Administration route: Oral
    Indication: Insomnia
    Start date: 2006-01-01
    End date: 2007-09-01

Imitrex
    Dosage: 50 mg, as required, per oral; 50 mg, as required, oral; 50 mg, as required, per oral
    Administration route: Oral
    Indication: Headache
    Start date: 2003-01-01
    End date: 2007-09-01

Imitrex
    Dosage: 50 mg, as required, per oral; 50 mg, as required, oral; 50 mg, as required, per oral
    Administration route: Oral
    Indication: Headache
    Start date: 2007-09-01

Unknown Sleep Medication (All Other Therapeutic Products)
    Indication: Sleep Disorder Therapy
    Start date: 2007-08-01
    End date: 2007-08-01

Other drugs received by patient: Vicodin; Flexeril; Unknown Anti-Inflammatory (All Other Therapeutic Products); Unknown Anti-Depressant (Antidepressants)



Adverse event in 69 year old male receiving Rozerem (Ramelteon)

Reported by a physician from United States on 2007-01-26

Patient: 69 year old male

Adverse reactions / side effects: Blood Bilirubin Increased, Alanine Aminotransferase Increased, International Normalised Ratio Increased, Liver Disorder, Blood Acid Phosphatase Increased, Brain Natriuretic Peptide Increased, Insomnia, Liver Function Test Abnormal

Adverse event resulted in: hospitalization

Suspect drug(s):
Rozerem
    Dosage: per oral
    Administration route: Oral
    Start date: 2006-11-13

Ambien

Other drugs received by patient: Lasix (Furosemide) (40 Milligram); Aspirin; Zocort (Simvastatin)

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009